Gene and cell therapies for the failing heart to prevent sudden arrhythmic death

A. A. Sovari, S. C. Dudley

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

Current therapies for treatment and prevention of sudden cardiac death have certain limitations, and a search for new therapeutic approaches is desirable to reduce the burden of sudden arrhythmic death. Gene therapy and stem cell therapy have been investigated as new, valuable tools in treating cardiac diseases such as arrhythmias. In this review, the basics of each modality, important related experimental and clinical studies, and potential advantages and limitations of these treatments will be discussed. The future success of gene and cell therapy to become practical clinical tools greatly depends on our understanding of the mechanisms of ventricular arrhythmia and the mechanisms of action of gene and cell therapy.

Original languageEnglish (US)
Pages (from-to)363-373
Number of pages11
JournalMinerva Cardioangiologica
Volume60
Issue number4
StatePublished - Aug 1 2012

Keywords

  • Death, sudden, cardiac
  • Gene therapy
  • Stem cell research
  • Tachycardia, ventricular

Fingerprint Dive into the research topics of 'Gene and cell therapies for the failing heart to prevent sudden arrhythmic death'. Together they form a unique fingerprint.

  • Cite this